Home/Filings/4/0001437749-23-032410
4//SEC Filing

Danahy Kevin Patrick 4

Accession 0001437749-23-032410

CIK 0001625101other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:11 AM ET

Size

6.9 KB

Accession

0001437749-23-032410

Insider Transaction Report

Form 4
Period: 2023-11-16
Danahy Kevin Patrick
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2023-11-16$6.52/sh+4,781$31,17235,275 total
  • Purchase

    Common Stock

    2023-11-16$6.51/sh+600$3,90635,875 total
  • Purchase

    Common Stock

    2023-11-16$6.50/sh+12$7835,887 total

Issuer

Pulse Biosciences, Inc.

CIK 0001625101

Entity typeother

Related Parties

1
  • filerCIK 0001913245

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:11 AM ET
Size
6.9 KB